TROVATO, Maria Concetta
 Distribuzione geografica
Continente #
EU - Europa 4.439
NA - Nord America 3.550
AS - Asia 2.166
SA - Sud America 771
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 11.006
Nazione #
US - Stati Uniti d'America 3.500
RU - Federazione Russa 2.109
SG - Singapore 953
BR - Brasile 672
CN - Cina 655
IE - Irlanda 533
SE - Svezia 524
FR - Francia 292
UA - Ucraina 252
HK - Hong Kong 244
DE - Germania 236
IT - Italia 201
FI - Finlandia 119
VN - Vietnam 99
GB - Regno Unito 88
IN - India 43
AR - Argentina 42
BD - Bangladesh 22
TR - Turchia 22
CA - Canada 20
MA - Marocco 20
BE - Belgio 18
IQ - Iraq 16
MX - Messico 16
NL - Olanda 14
ZA - Sudafrica 14
EC - Ecuador 11
ID - Indonesia 11
VE - Venezuela 11
JP - Giappone 10
UZ - Uzbekistan 10
CO - Colombia 9
PK - Pakistan 8
AZ - Azerbaigian 7
CL - Cile 7
CZ - Repubblica Ceca 7
EG - Egitto 7
ES - Italia 7
SA - Arabia Saudita 7
AL - Albania 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
IL - Israele 5
KE - Kenya 5
PY - Paraguay 5
RO - Romania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
KR - Corea 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
TN - Tunisia 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
SN - Senegal 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MM - Myanmar 2
MN - Mongolia 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 11.001
Città #
Moscow 620
Dublin 532
Singapore 512
Jacksonville 496
Ashburn 450
Chandler 351
Dallas 265
Beijing 257
Hong Kong 244
Nyköping 243
San Jose 109
The Dalles 108
Princeton 100
Cambridge 97
Lauterbourg 95
Ann Arbor 86
Medford 85
Los Angeles 77
Des Moines 69
Dearborn 60
Messina 50
Boardman 44
Council Bluffs 44
Buffalo 42
Munich 37
São Paulo 36
Wilmington 34
Ho Chi Minh City 33
Woodbridge 31
Bremen 29
Redondo Beach 29
New York 28
Jinan 27
Nanjing 23
San Mateo 23
Guangzhou 22
Rio de Janeiro 21
Tianjin 21
Belo Horizonte 20
Hanoi 19
Mazzarra Sant'andrea 19
Santa Clara 19
Brussels 18
Houston 17
Shenyang 16
Turku 16
Lancaster 15
Seattle 15
Brasília 14
Falls Church 14
Hangzhou 12
Orem 12
Taizhou 12
Shanghai 10
Tokyo 10
Zhengzhou 10
Chennai 9
Chicago 9
Curitiba 9
Haikou 9
Helsinki 9
London 9
Ribeirão Preto 9
Baghdad 8
Frankfurt am Main 8
Hillsboro 8
San Francisco 8
Sorocaba 8
Tashkent 8
Acireale 7
Brooklyn 7
Clearwater 7
Fuzhou 7
Gravataí 7
Hebei 7
Ningbo 7
Auburn Hills 6
Baku 6
Changsha 6
Denver 6
Haiphong 6
João Pessoa 6
Nova Iguaçu 6
Porto Alegre 6
Rome 6
Salvador 6
São José dos Campos 6
Atlanta 5
Betim 5
Buenos Aires 5
Cairo 5
Campinas 5
Carapicuíba 5
Casablanca 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Istanbul 5
Lahore 5
Leawood 5
Totale 5.989
Nome #
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 203
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 194
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 186
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 184
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 179
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 178
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 178
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 168
Realtà complesse ed epidemiologia di un fenomeno 167
Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 164
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 164
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 162
APLOTIPI DEL MICROSATELLITE D7S6440 INTERNO AL GENE HIPK2 COME MARCATORI DELLA TIROIDE AUTOIMMUNITARIA 156
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 153
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 153
Cellule giganti tipo corpo estraneo nel carcinoma papillare della tiroide 151
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 150
Deposito presso la GenBank della sequenza genica del microsatellite di 360 bp denominato “D7S6440”, trovato nell’Homo sapiens, localizzato nel cromosoma 7q 32-34, all’interno del gene HIPK2, a livello dell’introne 9; con tandem di ripetizione fra 173..198 bp costituito da sequenze “ca”. 149
Cancer Thyroid Nodule: Knowing is Doing 148
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 143
Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas 140
HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization 140
Cell-type specifc loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 139
Compared with healthy controls, serum hepatocyte growth factor (HGF) is increased in the nodular variant of Hashimoto's thyroiditis (HT) more than in the nonnodular variant, whereas serum interleukin-6 (IL-6) is increased regardless of associated thyroid nodules. 139
CD£0 ligand (CD30L)/CD30 receptor (CD30) signaling in benign and malignant thyroid nodules 138
Ultrastructural findings of thyrocytes are signatures for an accurate interpretation of cytological aspirates 133
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules. 132
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals 131
Thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer: a very rare association: case report and review of literature 129
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules: possible implications for pharmachologic treatment of the differentiated thyroid cancer (DTC). 128
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 128
Compendio di Anatomia Patologica 127
The new era of vaccines: the “nanovaccinology” 127
EGF, TGF-alpha, EGF receptor (EGFR) and somatostatin receptors 2 (SSR2) in acanthosis nigricans (AN) 118
The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization. 112
STAT3 is selectively expressed in papillary thyroid cancer (PTC) and some follicular adenomas 109
Espressione di CD30 e CD30 ligando nelle decidue di aborti spontanei 109
Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions 109
Multidrug resistance protein 2 (MRP2) nei carcinomi midollari della tiroide 107
Multidrug-resistance protein 2 (MRP-2) expression in medullary thyroid carcinoma. 107
What is New on Thyroid Cancer Biomarkers 107
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis 107
Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up 107
LACK OF SOMATOSTATIN ANALOGS (SSAS) EFFECTIVENESS IN GONADOTROPIN-SECRETING PITUITARY ADENOMAS: REPORT OF A CASE AND A REVIEW OF THE LITERATURE 104
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer 102
Espressione del CDX2 nelle varie fasi dello sviluppo placentare 102
Immunoexpression of the hepatocyte growth factor (HGF), HGF- receptor (c-met) and STAT3 on placental tissues from malformed fetuses 101
Perdita di eterozigosi su 7q21 nella patologia multinodulare della tiroide 99
New Research Communication on Thyroid Tumor Markers 97
Nanostructures: between natural environment and medical practice. 97
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. 96
METODO PER LA DIAGNOSI IN VITRO DI CARCINOMA TIROIDEO 96
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 95
Multidrug resistance protein-2 (MRP-2) nel carcinoma midollare della tiroide. 94
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas 94
L'espressione di STAT3 èpiù frequentemente associata al sistema HGF7c-met rispetto ad IL-6/IL6R nei carcinomi papillari e negli adenomi follicolari tiroidei 93
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions 93
Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. 92
Loss of heterozygosity for 7q21.1 and 31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancers 92
EGF, TGFA-apla, EGF receptor (EGFR) and somatostatin receptors (SSR2) in acanthosis nigricans (AN) 91
Distinctive expression of STAT3 in papillary thyroid carcinoma and a subset of follicular adenomas. 91
Expression of transcription factor STAT3 associated to HGF/c-met system in normal and pathological thyroid tissue. 91
Espressione immunoistochimica di HGF, c-met e STAT3 in placente da gravidanze con feti malformati 89
LOH sul braccio lungo del cromosoma 7 è una frequente alterazione genetica nel carcinoma follicolare ed anaplastico della tiroide. 89
La perdita di eterozigosità (LOH) per markers sul braccio lungo del cromosoma 7 (7q) è peculiare dei carcinomi tiroidei follicolari (FTC) e anaplastici (ATC), non dei papillari (PTC). 88
Prognostic and predictive biomarkers in thyroid diseases: “magic bullets” for a personalized therapeutic strategy 88
Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas 87
SELECTIVE RADIO-GUIDED NECK DISSECTION FOR CERVICAL LYMPH NODE METASTASIS FROM OCCULT THYROID CANCER: REPORT OF A CASE 87
MULTIDRUG-RESISTANCE PROTEIN 2 (MRP2) E CICLO-OSSIGENASI 2 (COX2) NEL CARCINOMA MIDOLLARE DELLA TIROIDE. 85
New Research Communication on Thyroid Tumor Markers 85
Hepatocyte growth factor (HGF) expression and circulating levels in nodular Hashimoto's thyroiditis. 84
THE LOSS OF THE P53 ACTIVATOR HIPK2 IS RESPONSIBLE FOR GALECTIN-3 OVEREXPRESSIONIN WELL DIFFERENTIATED THYROID CARCINOMAS 83
Immunodimostrazione dell'antigene K-1 (CD30) nella patologia autoimmune e neoplastica della tiroide. 82
Expression of IL6/IL6R and CD30L/C30 in normal thyroid and thyroid nodules. 82
Espressione genica della via p53/HGF/c-met /STAT3 nei feti con malformazioni del sistema nervoso. 81
Loss of heterozygosity of 7q21.1 and 7q31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancer. 81
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine 81
Expression of transcription factor STAY3 associated to HGF/c-met and IL-6/IL-6r sistems in normal and pathologic thyroid tissue 80
Espressione dei fattori della morfogenesi negli organi e nelle placente di feti a varie epoche di gestazione 80
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases 80
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer. 79
Hepatocyte growth factor (HGF) expression in nodular Hashimoto thyroditis. 78
Serum Levels And Immohistochemical Expression Of Hepatocyte Growth Factor (Hgf) in Hashimoto Thyroiditis 76
Serum levels and immunochemical expression of hepatocyte growth factor (HGF) in Hashimoto's thyroiditis. 76
EXPRESSION IN DECIDUAL SAMPLES OF SPONTANEOUS ABORTIONS. 76
Serum levels and immunohistochemical expression of Hepatocyte Growth Factor (HGF) in Hashimoto thyroiditis. 74
Espressione dlel'hepatocyte growth factor (HGF) e del suo recettore (HGF-R o c-met) nei carcinomi papillari tiroidei. 74
Serum Amyloid A (SAA) expression by medullary thyroid cancer (MTC). 74
Polimorfismo dle gene TP53 nrlla tiroidite di Hashimoto (TH). 73
Expression of HGF and HGF-receptor (c-met) in the papillary thyroid cancer (PTC). 71
Single Nucleotide Polymorphisms (SNPs) in exon 4 of p53 as genetic markers of susceptibility for Hashimoto’s thyroiditis (HT) 71
Serum amyloid A (SAA) expression in medullary thyroid cancer (MTC). 70
Dimostrazione immunocitochimica dell'Hepatocyte Growth Factor (HGF) e del suo recettore c-met nel tessuto tiroideo normale e patologico. 69
Immunohistochemical expression of HGF, c-met and transcription-factor STAT3 in colorectal tumors. 69
Expression of p53/ HGF/c-met/ STAT3 signal in fetus with malformation of nervous system. 67
Papillary and follicular thyroid carcinomas show LOH in two distinct regions of the long arm of chromosome 7 64
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects 62
Specific haplotypes of a microsatellite markers internal to the HIPK2 gene in Hashimoto thyroditis 62
Totale 11.080
Categoria #
all - tutte 37.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022683 6 86 20 34 31 7 44 32 14 110 103 196
2022/20231.524 123 107 64 102 123 171 16 94 653 3 55 13
2023/2024332 31 60 31 46 39 48 4 34 0 7 2 30
2024/20251.732 15 32 35 115 73 80 16 421 441 80 107 317
2025/20264.669 222 311 278 295 430 1.117 570 553 592 170 65 66
Totale 11.114